Home » Competitiveness and Regulation: The FDA and the Future of America's Biomedical Industry
Competitiveness and Regulation: The FDA and the Future of America's Biomedical Industry
Overview:
This report by the California Healthcare Institute (CHI) and the Boston Consulting Group (BCG) highlights the critical role of the FDA in today's biomedical research and innovation ecosystem, and the need for a strong, science-based agency and an efficient, consistent and transparent regulatory process.
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page